top of page

Bioactive Bone Substitutes

  • christopherbilmes
  • Oct 28, 2022
  • 1 min read

September 30 2021- RiverFort Provides €2M Convertible Facility to Fintech Health Technology Company.


In September 2021, RiverFort Global Capital arranged a convertible loan deal between Bioactive Bone Substitutes Oyj and RiverFort Global opportunities PCC Ltd. The facility had an aggregate commitment amount of up to €2,000,000 and a commitment period of 3 years. The initial commitment amount is between €500,000 – €750,000 with further tranches up to the aggregate commitment amount subject to mutual agreement. Funds were used towards achieving the CE-marking of the first product in addition to financing sales, marketing and operations.






Comments


riverfort-logo_white.png
Direct Investment.
Reinvented.
Any financial promotion contained herein has been issued and approved by Riverfort Global Capital; a firm authorised and regulated by the Financial Conduct Authority(Reg No:. 766760).
Location
162 Buckingham Palace Rd
London
SW1W 9TR
Contact
©2022 by RiverFort Global Capital
bottom of page